QQ, M., AP, W., HC, H., Y, J., YY, W., HJ, M., . . . KX, S. (2018). Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. Dove Medical Press.
Cita Chicago Style (17a ed.)QQ, Meng, Wang AP, Hua HC, Jiang Y, Wang YY, Mu HJ, Wu ZM, y Sun KX. Intranasal Delivery of Huperzine A to the Brain Using Lactoferrin-conjugated N-trimethylated Chitosan Surface-modified PLGA Nanoparticles for Treatment of Alzheimer’s Disease. Dove Medical Press, 2018.
Cita MLA (8a ed.)QQ, Meng, et al. Intranasal Delivery of Huperzine A to the Brain Using Lactoferrin-conjugated N-trimethylated Chitosan Surface-modified PLGA Nanoparticles for Treatment of Alzheimer’s Disease. Dove Medical Press, 2018.